متابعة
Dr. Ashish K. Rehni
Dr. Ashish K. Rehni
Postdoctoral Associate
بريد إلكتروني تم التحقق منه على miami.edu
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Transdermal patches: a recent approach to new drug delivery system
S Dhiman, TG Singh, AK Rehni
Int J Pharm Pharm Sci 3 (5), 26-34, 2011
2282011
Role of phosphoinositide 3-kinase in ischemic postconditioning-induced attenuation of cerebral ischemia-evoked behavioral deficits in mice
AK Rehni, N Singh
Pharmacological reports 59 (2), 192, 2007
1292007
Amniotic fluid derived stem cells ameliorate focal cerebral ischaemia-reperfusion injury induced behavioural deficits in mice
AK Rehni, N Singh, AS Jaggi, M Singh
Behavioural brain research 183 (1), 95-100, 2007
1132007
Ion exchange resins: Drug delivery and therapeutic applications
I Singh, AK Rehni, R Kalra, G Joshi, M Kumar, HY Aboul-Enein
Fabad Journal of Pharmaceutical Sciences 32 (2), 91, 2007
1092007
Tramadol‐induced seizurogenic effect: a possible role of opioid‐dependent γ‐aminobutyric acid inhibitory pathway
AK Rehni, I Singh, M Kumar
Basic & clinical pharmacology & toxicology 103 (3), 262-266, 2008
1032008
Pharmacological preconditioning of the brain: a possible interplay between opioid and calcitonin gene related peptide transduction systems.
AK Rehni, TG Singh, AS Jaggi, N Singh
Pharmacological Reports 60 (6), 904, 2008
972008
Tramadol-induced seizurogenic effect: a possible role of opioid-dependent histamine (H1) receptor activation-linked mechanism
AK Rehni, TG Singh, N Singh, S Arora
Naunyn-Schmiedeberg's archives of pharmacology 381, 11-19, 2010
822010
Impact of hypoglycemia on brain metabolism during diabetes
AK Rehni, KR Dave
Molecular neurobiology 55 (12), 9075-9088, 2018
762018
Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors
D Della-Morte, R Palmirotta, AK Rehni, D Pastore, B Capuani, F Pacifici, ...
Pharmacogenomics 15 (16), 2063-2082, 2014
752014
Opioid withdrawal syndrome: emerging concepts and novel therapeutic targets
A K Rehni, A S Jaggi, N Singh
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2013
752013
Carbon nanotubes: synthesis, properties and pharmaceutical applications
I Singh, AK Rehni, P Kumar, M Kumar, HY Aboul‐Enein
Fullerenes, Nanotubes and Carbon Nanostructures 17 (4), 361-377, 2009
702009
Effect of chlorophyll and aqueous extracts of Bacopa monniera and Valeriana wallichii on ischaemia and reperfusion-induced cerebral injury in mice
AK Rehni, HS Pantlya, R Shri, M Singh
CSIR, 2007
592007
Hyperglycemia/hypoglycemia-induced mitochondrial dysfunction and cerebral ischemic damage in diabetics
AK Rehni, N Nautiyal, MA Perez-Pinzon, KR Dave
Metabolic brain disease 30, 437-447, 2015
552015
Gastroretentive: a controlled release drug delivery system
S Dhiman, TG Singh, AK Rehni, S Sood, S Arora
Asian J Pharm Clin Res 4 (SUPPL 1), 5-13, 2011
492011
Pharmacological inhibition of inducible nitric oxide synthase attenuates the development of seizures in mice
AK Rehni, TG Singh, R Kalra, N Singh
Nitric Oxide 21 (2), 120-125, 2009
492009
Possible involvement of insulin, endogenous opioids and calcitonin gene related peptide in remote ischaemic preconditioning of brain
AK Rehni, N Singh, AS Jaggi
Yakugaku zasshi 127 (6), 1013-1020, 2007
482007
Dendrimers and their pharmaceutical applications–a review
I Singh, AK Rehni, R Kalra, G Joshi, M Kumar
Die Pharmazie-An International Journal of Pharmaceutical Sciences 63 (7 …, 2008
472008
Reviving mitochondrial bioenergetics: a relevant approach in epilepsy
S Singh, TG Singh, AK Rehni, V Sharma, M Singh, R Kaur
Mitochondrion 58, 213-226, 2021
462021
Remote ischaemic preconditioning and prevention of cerebral injury
AK Rehni, R Shri, M Singh
CSIR, 2007
462007
Involvement of CCR-2 chemokine receptor activation in ischemic preconditioning and postconditioning of brain in mice
AK Rehni, TG Singh
Cytokine 60 (1), 83-89, 2012
402012
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20